GB2408932A - Control of cancer with annonaceous extracts - Google Patents

Control of cancer with annonaceous extracts Download PDF

Info

Publication number
GB2408932A
GB2408932A GB0506460A GB0506460A GB2408932A GB 2408932 A GB2408932 A GB 2408932A GB 0506460 A GB0506460 A GB 0506460A GB 0506460 A GB0506460 A GB 0506460A GB 2408932 A GB2408932 A GB 2408932A
Authority
GB
United Kingdom
Prior art keywords
annonaceous
cancer
extracts
control
crude extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0506460A
Other versions
GB0506460D0 (en
Inventor
Jerry L Mclaughlin
Gina B Benson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natures Sunshine Products Inc
Original Assignee
Natures Sunshine Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natures Sunshine Products Inc filed Critical Natures Sunshine Products Inc
Publication of GB0506460D0 publication Critical patent/GB0506460D0/en
Publication of GB2408932A publication Critical patent/GB2408932A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

A crude extract composition derived from the plant family Annonaceae and the method for producing the crude extract composition. Medicinal benefits of the extract include tumor regression and the reduction of tumor antigen levels.

Description

GB 2408932 A continuation (74) Agent and/or Address for Service: Greaves
Brewster Indigo House, Cheddar Business Park, Wedmore Road, CHEDDAR, Somerset, BS27 3EB, United Kingdom
GB0506460A 2002-11-22 2003-11-21 Control of cancer with annonaceous extracts Withdrawn GB2408932A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42860202P 2002-11-22 2002-11-22
US10/717,746 US20040101584A1 (en) 2002-11-22 2003-11-20 Control of cancer with annonaceous extracts
PCT/US2003/037484 WO2004048358A1 (en) 2002-11-22 2003-11-21 Control of cancer with annonaceous extracts

Publications (2)

Publication Number Publication Date
GB0506460D0 GB0506460D0 (en) 2005-05-04
GB2408932A true GB2408932A (en) 2005-06-15

Family

ID=32329251

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0506460A Withdrawn GB2408932A (en) 2002-11-22 2003-11-21 Control of cancer with annonaceous extracts

Country Status (6)

Country Link
US (2) US20040101584A1 (en)
AU (1) AU2003295850A1 (en)
CA (1) CA2501493A1 (en)
GB (1) GB2408932A (en)
NZ (1) NZ539141A (en)
WO (1) WO2004048358A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780645B2 (en) * 2004-10-26 2010-08-24 Codman & Shurtleff, Inc. Method of delivering embolic particles to an aneurysm
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
ES2546402T3 (en) * 2007-10-03 2015-09-23 Sabell Corporation Herbal compositions and methods to treat liver disorders
CN102552349A (en) * 2012-02-23 2012-07-11 中国医学科学院药用植物研究所 Application of TTAs (total annonaceous acetogenins) in preparing anti-tumor medicine
US10603270B2 (en) * 2013-10-30 2020-03-31 Unigen, Inc. Skin care compositions and methods of use thereof
CN106543117B (en) * 2016-11-10 2019-01-22 南京中医药大学 With anti-tumor activity double tetrahydrofuran type Annonaceousacetogenicompounds compounds and the preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536848A (en) * 1994-06-14 1996-07-16 Purdue Research Foundation Bioactive acetogenins and derivatives
JPH0912433A (en) * 1995-04-28 1997-01-14 Shiseido Co Ltd Composition for head
JP2001064145A (en) * 1999-08-25 2001-03-13 Lion Corp Composition for external use
US20020103389A1 (en) * 2000-12-05 2002-08-01 Sabine Haag Klainetins and their derivatives, method for their preparation and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855319A (en) * 1986-05-06 1989-08-08 The United States Of America As Represented By The Secretary Of Agriculture Control of pests with annonaceous acetogenins
US5229419A (en) * 1989-04-11 1993-07-20 Purdue Research Foundation Chemotherapeutically active acetogenins
US5955497A (en) * 1997-02-25 1999-09-21 Purdue Research Foundation Bioactive acetogenins
AU7280998A (en) * 1997-05-05 1998-11-27 Purdue Research Foundation Selectively cytotoxic acetogenin compounds
US20020103386A1 (en) * 1999-10-14 2002-08-01 Therezinha C. B. Tomassini Process for isolating physalins from plants and pharmaceutical compositions containing physalins
US6991818B2 (en) * 2001-03-30 2006-01-31 Council Of Scientific & Industrial Research Compound iso-squamocin obtained from seeds of annona squamosa and composition containing the same
US20050266105A1 (en) * 2004-02-19 2005-12-01 Ashiagbor Kwame T Compositions comprising natural agents for the treatment of HIV-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536848A (en) * 1994-06-14 1996-07-16 Purdue Research Foundation Bioactive acetogenins and derivatives
JPH0912433A (en) * 1995-04-28 1997-01-14 Shiseido Co Ltd Composition for head
JP2001064145A (en) * 1999-08-25 2001-03-13 Lion Corp Composition for external use
US20020103389A1 (en) * 2000-12-05 2002-08-01 Sabine Haag Klainetins and their derivatives, method for their preparation and use thereof

Also Published As

Publication number Publication date
WO2004048358A1 (en) 2004-06-10
NZ539141A (en) 2007-11-30
GB0506460D0 (en) 2005-05-04
CA2501493A1 (en) 2004-06-10
US20090182041A1 (en) 2009-07-16
AU2003295850A1 (en) 2004-06-18
US20040101584A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
ATE344045T1 (en) STORAGE-Stable, CITRUS-FLAVORED COMPOSITIONS CONTAINING PLANT EXTRACTS
AU2002213363A1 (en) Method for the oxidation of aldehydes, hemiacetals and primary alcohols
WO2002017914A3 (en) Fused pyrrolocarbazoles against inflammation
WO2000062765A3 (en) ESTROGEN RECEPTOR-β LIGANDS
NO993979L (en) Procedures to prevent and delay the onset of Alzheimer's disease and its composition
WO2002047708A3 (en) Selective cox-2 inhibition from edible plant extracts
DE60018793D1 (en) ODOR-BASED HYDROCARBON PREPARATION
ATE185971T1 (en) COMBINATION PREPARATION FOR THE TREATMENT OF HYPOGONADAL MEN AND MEN WITH HYPOPHYSIS DISEASES
WO2001079460A3 (en) Polypeptides having haloperoxidase activity
WO2001079458A3 (en) Polypeptides having haloperoxidase activity
GB2400220A (en) Methods and systems for providing crossing markets
WO2004050026A3 (en) Compositions and methods for treating prostate cancer
GB2396464A (en) Systems and methods for providing interactive assistance on purchase decision-making
AU2003273176A8 (en) Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
AU2002353414A1 (en) Development of an anti-cough, anti-tussive and throat soothing herbal formulation
GB2408932A (en) Control of cancer with annonaceous extracts
WO2002091858A8 (en) Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
GB2395737A (en) Drillable junction joint
Mead Proto-Bungku-Tolaki: Reconstruction of its phonology and aspects of its morphosyntax
WO2002039122A3 (en) Methods for the identification and the treatment of cardiovascular disease
WO2002005642A3 (en) Synergistic biocidal compositions
IS6433A (en) Method for producing citalopram
GB2410764A (en) A method and apparatus for creating a cemented lateral junction system
WO2002085302A3 (en) Methods of treating intestinal inflammation

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)